The key point from the paper [1]:
>Decreased depressive symptoms were observed in all 19 patients at 1-week post-treatment and 47% met criteria for response at 5 weeks.
Small sample size, but definitely an interesting result. I was hoping they'd test again after a few months have passed, though.